Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 223

1.

Repeated viral meningitis in a newborn.

Alhazmi A, Lazrek M, Alidjinou EK, Engelmann I, Schuffenecker I, Dubos F, Hober D.

J Neurovirol. 2020 Feb 5. doi: 10.1007/s13365-020-00829-0. [Epub ahead of print]

PMID:
32026339
2.

For Debate: Programing of the Autoimmune Diabetogenic Response in the Thymus during Fetal and Perinatal Life.

Geenen V, Hober D.

Pediatr Endocrinol Rev. 2019 Dec;17(2):78-83. doi: 10.17458/per.vol17.2019.gh.fd.autoimmunediabetogenicthymus. No abstract available.

PMID:
31763800
3.

Human Endogenous Retroviruses and Type 1 Diabetes.

Levet S, Charvet B, Bertin A, Deschaumes A, Perron H, Hober D.

Curr Diab Rep. 2019 Nov 21;19(12):141. doi: 10.1007/s11892-019-1256-9. Review.

4.

Paediatric enterovirus meningitis without cerebrospinal fluid pleocytosis.

Alhazmi A, Lazrek M, Alidjinou EK, Descombes G, Engelmann I, Hober D.

J Infect. 2019 Dec;79(6):612-625. doi: 10.1016/j.jinf.2019.11.006. Epub 2019 Nov 13. No abstract available.

PMID:
31733234
5.

Routine drug resistance testing in HIV-1 proviral DNA, using an automated next- generation sequencing assay.

Alidjinou EK, Coulon P, Hallaert C, Robineau O, Meybeck A, Huleux T, Ajana F, Hober D, Bocket L.

J Clin Virol. 2019 Dec;121:104207. doi: 10.1016/j.jcv.2019.104207. Epub 2019 Nov 2.

PMID:
31707202
6.

Does control of glycemia regulate immunological parameters in insulin-treated persons with type 1 diabetes?

Nekoua MP, Fachinan R, Fagninou A, Alidjinou EK, Moutairou K, Hober D, Yessoufou A.

Diabetes Res Clin Pract. 2019 Nov;157:107868. doi: 10.1016/j.diabres.2019.107868. Epub 2019 Sep 24.

PMID:
31560963
7.

Impact of coxsackievirus-B4E2 combined with a single low dose of streptozotocin on pancreas of outbred mice: investigation of viral load, pathology and inflammation.

Benkahla MA, Sane F, Bertin A, Vreulx AC, Elmastour F, Jaidane H, Desailloud R, Hober D.

Sci Rep. 2019 Jul 12;9(1):10080. doi: 10.1038/s41598-019-46227-3.

8.

Coxsackievirus-B4 Infection of Human Primary Pancreatic Ductal Cell Cultures Results in Impairment of Differentiation into Insulin-Producing Cells.

Bertin A, Sane F, Gmyr V, Lobert D, Dechaumes A, Kerr-Conte J, Pattou F, Hober D.

Viruses. 2019 Jul 2;11(7). pii: E597. doi: 10.3390/v11070597.

9.

Pancreatic beta cells persistently infected with coxsackievirus B4 are targets of NK cell-mediated cytolytic activity.

Nekoua MP, Bertin A, Sane F, Alidjinou EK, Lobert D, Trauet J, Hober C, Engelmann I, Moutairou K, Yessoufou A, Hober D.

Cell Mol Life Sci. 2020 Jan;77(1):179-194. doi: 10.1007/s00018-019-03168-4. Epub 2019 Jun 6.

PMID:
31172216
10.

Evaluation of the reverse transcription strand invasion based amplification (RT-SIBA) RSV assay, a rapid molecular assay for the detection of respiratory syncytial virus.

Alidjinou EK, Lefebvre N, Dewilde A, Mäki M, Hober D, Engelmann I.

Diagn Microbiol Infect Dis. 2019 Sep;95(1):55-58. doi: 10.1016/j.diagmicrobio.2019.04.006. Epub 2019 Apr 26.

PMID:
31160164
11.

Emergence of Fluoxetine-Resistant Variants during Treatment of Human Pancreatic Cell Cultures Persistently Infected with Coxsackievirus B4.

Alidjinou EK, Bertin A, Sane F, Caloone D, Engelmann I, Hober D.

Viruses. 2019 May 28;11(6). pii: E486. doi: 10.3390/v11060486.

12.

Routine drug resistance testing in proviral HIV-1 DNA: Prevalence of stop codons and hypermutation, and associated factors.

Alidjinou EK, Deldalle J, Robineau O, Hallaert C, Meybeck A, Huleux T, Ajana F, Hober D, Bocket L.

J Med Virol. 2019 Sep;91(9):1684-1687. doi: 10.1002/jmv.25474. Epub 2019 Apr 13.

PMID:
30927451
13.

Aqueous extracts of Syzygium brazzavillense can inhibit the infection with coxsackievirus B4 in vitro.

Badia-Boungou F, Sane F, Alidjinou EK, Hennebelle T, Roumy V, Ngakegni-Limbili AC, Nguimbi E, Moukassa D, Abena AA, Hober D.

J Med Virol. 2019 Jul;91(7):1210-1216. doi: 10.1002/jmv.25436. Epub 2019 Mar 3.

PMID:
30788849
14.

Diabetes progression and alterations in gut bacterial translocation: prevention by diet supplementation with human milk in NOD mice.

Sane F, Scuotto A, Pierrat V, Kacet N, Hober D, Romond MB.

J Nutr Biochem. 2018 Dec;62:108-122. doi: 10.1016/j.jnutbio.2018.08.017. Epub 2018 Oct 4.

PMID:
30292969
15.

Fluoxetine can inhibit coxsackievirus-B4 E2 in vitro and in vivo.

Benkahla MA, Alidjinou EK, Sane F, Desailloud R, Hober D.

Antiviral Res. 2018 Nov;159:130-133. doi: 10.1016/j.antiviral.2018.10.002. Epub 2018 Oct 2.

PMID:
30290197
16.

Serum-derived IgG from coxsackievirus A6-infected patients can enhance the infection of peripheral blood mononuclear cells with coxsackievirus A6.

Aswathyraj S, Sane F, Raghu C, Sabeena S, Alidjinou EK, Arunkumar G, Hober D.

Microb Pathog. 2018 Dec;125:7-11. doi: 10.1016/j.micpath.2018.08.064. Epub 2018 Sep 4.

PMID:
30193952
17.

miRNAs in enterovirus infection.

Engelmann I, Alidjinou EK, Bertin A, Sane F, Hober D.

Crit Rev Microbiol. 2018 Nov;44(6):701-714. doi: 10.1080/1040841X.2018.1499608. Epub 2018 Aug 14. Review.

PMID:
30106324
18.

Coxsackievirus-B4E2 can infect monocytes and macrophages in vitro and in vivo.

Benkahla MA, Elmastour F, Sane F, Vreulx AC, Engelmann I, Desailloud R, Jaidane H, Alidjinou EK, Hober D.

Virology. 2018 Sep;522:271-280. doi: 10.1016/j.virol.2018.06.010. Epub 2018 Jul 26.

19.

Investigation of the role of GBF1 in the replication of positive-sense single-stranded RNA viruses.

Ferlin J, Farhat R, Belouzard S, Cocquerel L, Bertin A, Hober D, Dubuisson J, Rouillé Y.

J Gen Virol. 2018 Aug;99(8):1086-1096. doi: 10.1099/jgv.0.001099. Epub 2018 Jun 20.

PMID:
29923822
20.

Salivary anti-coxsackievirus-B4 neutralizing activity and pattern of immune parameters in patients with type 1 diabetes: a pilot study.

Nekoua MP, Yessoufou A, Alidjinou EK, Badia-Boungou F, Moutairou K, Sane F, Hober D.

Acta Diabetol. 2018 Aug;55(8):827-834. doi: 10.1007/s00592-018-1158-3. Epub 2018 May 17.

PMID:
29774468
21.

Relapsing Pityriasis Rosea With HHV-7 Reactivation in an 11-Year-Old Girl.

Engelmann I, Ogiez J, Ogiez L, Alidjinou EK, Lazrek M, Dewilde A, Hober D.

Pediatrics. 2018 May;141(5). pii: e20173179. doi: 10.1542/peds.2017-3179. Epub 2018 Apr 19.

22.

Inhibition of coxsackievirus B4 by Lactobacillus plantarum.

Arena MP, Elmastour F, Sane F, Drider D, Fiocco D, Spano G, Hober D.

Microbiol Res. 2018 May;210:59-64. doi: 10.1016/j.micres.2018.03.008. Epub 2018 Mar 19.

23.

Comparison of two commercial quantitative PCR assays for EBV DNA detection and their correlation with the first WHO International Standard for EBV.

Engelmann I, Alidjinou EK, Lazrek M, Pouillaude JM, Ogiez J, Rose F, Duhamel A, Dewilde A, Hober D.

J Med Microbiol. 2018 Apr;67(4):529-536. doi: 10.1099/jmm.0.000702. Epub 2018 Feb 26.

PMID:
29480795
24.

Comparison of two commercial quantitative PCR assays and correlation with the first WHO International Standard for human CMV.

Engelmann I, Alidjinou EK, Lazrek M, Ogiez J, Pouillaude JM, Chazard E, Dewilde A, Hober D.

Diagn Microbiol Infect Dis. 2018 May;91(1):27-33. doi: 10.1016/j.diagmicrobio.2017.12.021. Epub 2018 Jan 7.

PMID:
29463426
25.

Necrotizing Enterocolitis Cases Associated with Nosocomial Enterovirus Transmission in a Neonatal Unit.

Alidjinou EK, Lazrek M, Schuffenecker I, Pindi B, Lapeyre F, Kacet N, Dewilde A, Engelmann I, Hober D.

Pediatr Infect Dis J. 2018 Sep;37(9):954-957. doi: 10.1097/INF.0000000000001928.

PMID:
29389824
26.

Diabetes: Towards a coxsackievirus B-based vaccine to combat T1DM.

Hober D, Alidjinou EK.

Nat Rev Endocrinol. 2018 Mar;14(3):131-132. doi: 10.1038/nrendo.2017.184. Epub 2018 Jan 12. No abstract available.

PMID:
29327705
27.

Very slow decline of hepatitis B virus surface antigen and core related antigen in chronic hepatitis B patients successfully treated with nucleos(t)ide analogues.

Alidjinou EK, Michel C, Canva V, Ajana F, Hober D, Bocket L.

J Med Virol. 2018 May;90(5):989-993. doi: 10.1002/jmv.25028. Epub 2018 Jan 30.

PMID:
29315722
28.

Sanger sequencing versus INNO-LiPA® HBV PreCore assay for routine detection of precore and basal core promoter mutations in hepatitis virus B chronically infected patients.

Alidjinou EK, Bocket L, Pigot V, Lambert V, Hallaert C, Canva V, Hober D.

Diagn Microbiol Infect Dis. 2018 Apr;90(4):277-279. doi: 10.1016/j.diagmicrobio.2017.12.006. Epub 2017 Dec 17.

PMID:
29310947
29.

Quantification of the first WHO International Standard for BK virus DNA by an automated PCR assay.

Engelmann I, Alidjinou EK, Pouillaude JM, Ogiez J, Dewilde A, Hober D.

Curr Res Transl Med. 2018 Mar;66(1):33-34. doi: 10.1016/j.retram.2017.11.001. Epub 2017 Dec 26. No abstract available.

PMID:
29287698
30.

Virus-triggered exacerbation in allergic asthmatic children: neutrophilic airway inflammation and alteration of virus sensors characterize a subgroup of patients.

Deschildre A, Pichavant M, Engelmann I, Langlois C, Drumez E, Pouessel G, Boileau S, Romero-Cubero D, Decleyre-Badiu I, Dewilde A, Hober D, Néve V, Thumerelle C, Lejeune S, Mordacq C, Gosset P.

Respir Res. 2017 Nov 14;18(1):191. doi: 10.1186/s12931-017-0672-0.

31.

RNA and DNA Sanger sequencing versus next-generation sequencing for HIV-1 drug resistance testing in treatment-naive patients.

Alidjinou EK, Deldalle J, Hallaert C, Robineau O, Ajana F, Choisy P, Hober D, Bocket L.

J Antimicrob Chemother. 2017 Oct 1;72(10):2823-2830. doi: 10.1093/jac/dkx232.

PMID:
29091197
32.

Antiviral Properties of Chemical Inhibitors of Cellular Anti-Apoptotic Bcl-2 Proteins.

Bulanova D, Ianevski A, Bugai A, Akimov Y, Kuivanen S, Paavilainen H, Kakkola L, Nandania J, Turunen L, Ohman T, Ala-Hongisto H, Pesonen HM, Kuisma MS, Honkimaa A, Walton EL, Oksenych V, Lorey MB, Guschin D, Shim J, Kim J, Than TT, Chang SY, Hukkanen V, Kulesskiy E, Marjomaki VS, Julkunen I, Nyman TA, Matikainen S, Saarela JS, Sane F, Hober D, Gabriel G, De Brabander JK, Martikainen M, Windisch MP, Min JY, Bruzzone R, Aittokallio T, Vähä-Koskela M, Vapalahti O, Pulk A, Velagapudi V, Kainov DE.

Viruses. 2017 Sep 25;9(10). pii: E271. doi: 10.3390/v9100271.

33.

Enteroviruses in blood of patients with type 1 diabetes detected by integrated cell culture and reverse transcription quantitative real-time PCR.

Alidjinou EK, Sane F, Lefevre C, Baras A, Moumna I, Engelmann I, Vantyghem MC, Hober D.

Acta Diabetol. 2017 Nov;54(11):1025-1029. doi: 10.1007/s00592-017-1041-7. Epub 2017 Aug 31.

PMID:
28861621
34.

Evaluation of Contamination Risks with Coxsackievirus B4 E2 in Swiss Albino Mice Stools.

Aguech-Oueslati L, Jaidane H, Sane F, Jrad-Battikh N, Hamed SB, Hober D, Gharbi J.

Curr Microbiol. 2018 Jan;75(1):32-39. doi: 10.1007/s00284-017-1347-2. Epub 2017 Aug 30.

PMID:
28856411
35.

Marker of coxsackievirus-B4 infection in saliva of patients with type 1 diabetes.

Badia-Boungou F, Sane F, Alidjinou EK, Ternois M, Opoko PA, Haddad J, Stukens C, Lefevre C, Gueorguieva I, Hamze M, Ismail M, Weill J, Monabéka HG, Bouenizabila E, Moukassa D, Abena AA, Hober D.

Diabetes Metab Res Rev. 2017 Oct;33(7). doi: 10.1002/dmrr.2916. Epub 2017 Aug 30.

PMID:
28719027
36.

Resistance of Enteric Viruses on Fomites.

Alidjinou EK, Sane F, Firquet S, Lobert PE, Hober D.

Intervirology. 2018;61(5):205-213. doi: 10.1159/000448807. Epub 2017 Jun 15. Review.

37.

Persistent coxsackievirus B4 infection induces microRNA dysregulation in human pancreatic cells.

Engelmann I, Alidjinou EK, Bertin A, Bossu J, Villenet C, Figeac M, Sane F, Hober D.

Cell Mol Life Sci. 2017 Oct;74(20):3851-3861. doi: 10.1007/s00018-017-2567-0. Epub 2017 Jun 10.

PMID:
28601984
38.

Bifidobacteria-derived lipoproteins inhibit infection with coxsackievirus B4 in vitro.

El Kfoury KA, Romond MB, Scuotto A, Alidjinou EK, Dabboussi F, Hamze M, Engelmann I, Sane F, Hober D.

Int J Antimicrob Agents. 2017 Aug;50(2):177-185. doi: 10.1016/j.ijantimicag.2017.03.010. Epub 2017 Jun 17.

PMID:
28595938
39.

Necessity to critically review the automatic results of the Xpert Flu assay.

Engelmann I, Alidjinou EK, Lazrek M, Dewilde A, Hober D.

Diagn Microbiol Infect Dis. 2017 May;88(1):26-30. doi: 10.1016/j.diagmicrobio.2017.01.015. Epub 2017 Feb 2.

PMID:
28214222
40.

Enterovirus D68 detection in respiratory specimens: Association with severe disease.

Engelmann I, Fatoux M, Lazrek M, Alidjinou EK, Mirand A, Henquell C, Dewilde A, Hober D.

J Med Virol. 2017 Jul;89(7):1201-1207. doi: 10.1002/jmv.24772. Epub 2017 Mar 28.

PMID:
28165146
41.

In Vivo Persistence of Human Rhinoviruses in Immunosuppressed Patients.

Engelmann I, Dewilde A, Lazrek M, Batteux M, Hamissi A, Yakoub-Agha I, Hober D.

PLoS One. 2017 Feb 2;12(2):e0170774. doi: 10.1371/journal.pone.0170774. eCollection 2017. Erratum in: PLoS One. 2017 Jul 13;12 (7):e0181296.

42.

Persistence of Coxsackievirus B4 in pancreatic ductal-like cells results in cellular and viral changes.

Alidjinou EK, Engelmann I, Bossu J, Villenet C, Figeac M, Romond MB, Sané F, Hober D.

Virulence. 2017 Oct 3;8(7):1229-1244. doi: 10.1080/21505594.2017.1284735. Epub 2017 Jan 23.

43.

The history of plasma viral load and CD4 count impacts the size of HIV-1 reservoir.

Alidjinou EK, Robineau O, Chéret A, Ajana F, Drumez E, Kyheng M, Choisy P, Hober D, Bocket L.

J Infect. 2017 Apr;74(4):420-422. doi: 10.1016/j.jinf.2016.12.002. Epub 2016 Dec 18. No abstract available.

PMID:
27998749
44.

Anti-coxsackievirus B4 (CV-B4) enhancing activity of serum associated with increased viral load and pathology in mice reinfected with CV-B4.

Elmastour F, Jaïdane H, Benkahla M, Aguech-Oueslati L, Sane F, Halouani A, Engelmann I, Bertin A, Mokni M, Gharbi J, Aouni M, Alidjinou EK, Hober D.

Virulence. 2017 Aug 18;8(6):908-923. doi: 10.1080/21505594.2016.1252018. Epub 2016 Oct 28.

45.

In-utero coxsackievirus B4 infection of the mouse thymus.

Jaïdane H, Halouani A, Jmii H, Elmastour F, Abdelkefi S, Bodart G, Michaux H, Chakroun T, Sane F, Mokni M, Geenen V, Hober D, Aouni M.

Clin Exp Immunol. 2017 Mar;187(3):399-407. doi: 10.1111/cei.12893. Epub 2016 Nov 29.

46.

Exposure of Piglets to Enteroviruses Investigated by an Immunoassay Based on the EV-G1 VP4 Peptide.

Benkahla MA, Sane F, Desailloud R, Hober D.

Intervirology. 2016;59(2):69-73. doi: 10.1159/000449058. Epub 2016 Oct 1.

47.

Central nervous system infection following vertical transmission of Coxsackievirus B4 in mice.

Jmii H, Halouani A, Elmastour F, Ifie E, Richardson SJ, Sane F, Mokni M, Aouni M, Hober D, Jaïdane H.

Pathog Dis. 2016 Nov;74(8). pii: ftw096. doi: 10.1093/femspd/ftw096. Epub 2016 Sep 20.

PMID:
27655912
48.

Hand, foot and mouth disease (HFMD): emerging epidemiology and the need for a vaccine strategy.

Aswathyraj S, Arunkumar G, Alidjinou EK, Hober D.

Med Microbiol Immunol. 2016 Oct;205(5):397-407. doi: 10.1007/s00430-016-0465-y. Epub 2016 Jul 12. Review.

PMID:
27406374
49.

Clinical severity and molecular characteristics of circulating and emerging rotaviruses in young children attending hospital emergency departments in France.

de Rougemont A, Kaplon J, Fremy C, Legrand-Guillien MC, Minoui-Tran A, Payan C, Vabret A, Mendes-Martins L, Chouchane M, Maudinas R, Huet F, Dubos F, Hober D, Lazrek M, Bouquignaud C, Decoster A, Alain S, Languepin J, Gillet Y, Lina B, Mekki Y, Morfin-Sherpa F, Guigon A, Guinard J, Foulongne V, Rodiere M, Avettand-Fenoel V, Bonacorsi S, Garbarg-Chenon A, Gendrel D, Lebon P, Lorrot M, Mariani P, Meritet JF, Schnuriger A, Agius G, Beby-Defaux A, Oriot D, Colimon R, Lagathu G, Mory O, Pillet S, Pozzetto B, Stephan JL, Aho S, Pothier P; French National Rotavirus Network.

Clin Microbiol Infect. 2016 Aug;22(8):737.e9-737.e15. doi: 10.1016/j.cmi.2016.05.025. Epub 2016 Jun 7.

50.

Severe Adenovirus Pneumonia Followed by Bacterial Septicaemia: Relevance of Co-Infections in Allogeneic Hematopoietic Stem Cell Transplantation.

Engelmann I, Coiteux V, Heim A, Magro L, Dewilde A, Dulery R, Hober D, Yakoub-Agha I.

Infect Disord Drug Targets. 2016;16(1):69-76.

PMID:
27052333

Supplemental Content

Support Center